Henry Gómez

26.3k citations
208 papers · 8.3k · 3 hit papers · h-index 46

Impact in

  • Oncology top 0.2%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Treatment and Pharmacology 59
    • HER2/EGFR in Cancer Research 38
    • Breast Cancer Treatment Studies 53
    • Cancer Genomics and Diagnostics 15

Henry Gómez

199 papers receiving 8.2k citations

Henry Gómez's Hit Papers

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation 2017 · 487 citations
4870+6+13Years since publication250500750

Peers

Henry Gómez
Comparison fields: 5 of 152
  • Oncology 4.3k
  • Cancer Research 2.1k
  • Pulmonary and Respiratory Medicine 1.4k
  • Genetics 337
  • Molecular Biology 2.2k
Replace Nuhad K. Ibrahim with:
Nuhad K. Ibrahim United States
Fabio Puglisi Italy
Rebecca Dent Singapore
William T. Barry United States
Stephen Chan United Kingdom
Christoph Thomssen Germany
Philippe L. Bédard Canada
Maura N. Dickler United States
Lori J. Goldstein United States
Daniel J. Booser United States
Henry Gómez relative to Nuhad K. Ibrahim United States Nuhad K. Ibrahim's profile →
Citations per field
00.5×1.5×
Nuhad K. Ibrahim · 1×
Citations per year

Countries citing papers authored by Henry Gómez

Since Specialization
Citations

This map shows the geographic impact of Henry Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Gómez more than expected).

Fields of papers citing papers by Henry Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Gómez. The network helps show where Henry Gómez may publish in the future.

Co-authors

The 25 scholars most cited alongside Henry Gómez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Gómez Line = papers co-authored together Henry Gómez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
Hit paper breakdown →
2009768
2
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer
Hit paper breakdown →
2006553
3
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Hit paper breakdown →
2017487
4 2011444
5 2007383
6 2008348
7 2008266
8 2014258
9 2012200
10 2010162
11 1991145
12 2010142
13 2007137
14 1998133
15 2013125
16 2016118
17 1998116
18 2013115
19 2010114
20 2010114

About Henry Gómez

Henry Gómez is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 208 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (59 papers), Breast Cancer Treatment Studies (53 papers), HER2/EGFR in Cancer Research (38 papers), Advanced Breast Cancer Therapies (38 papers), Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Oncology (4.3k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (1.4k citations), Genetics (337 citations) and Molecular Biology (2.2k citations). Henry Gómez has collaborated with scholars based in Peru, United States and Spain. Frequent co-authors include Justin M. Balko, Carlos L. Arteaga, Cristina Oliva, Xavier Pivot, Michael F. Press, Carlos A. Castañeda, Tatiana Vidaurre, Melinda E. Sanders, Joseph A. Pinto and H. Cortés-Funes. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Treatment and Clinical Breast Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact